Hans L. Hillege

51.0k total citations · 12 hit papers
386 papers, 27.9k citations indexed

About

Hans L. Hillege is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hans L. Hillege has authored 386 papers receiving a total of 27.9k indexed citations (citations by other indexed papers that have themselves been cited), including 253 papers in Cardiology and Cardiovascular Medicine, 68 papers in Nephrology and 62 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hans L. Hillege's work include Heart Failure Treatment and Management (123 papers), Cardiovascular Function and Risk Factors (48 papers) and Blood Pressure and Hypertension Studies (44 papers). Hans L. Hillege is often cited by papers focused on Heart Failure Treatment and Management (123 papers), Cardiovascular Function and Risk Factors (48 papers) and Blood Pressure and Hypertension Studies (44 papers). Hans L. Hillege collaborates with scholars based in Netherlands, United Kingdom and United States. Hans L. Hillege's co-authors include Dirk J. van Veldhuisen, Adriaan A. Voors, Dick de Zeeuw, Paul E. de Jong, Kevin Damman, Wiek H. van Gilst, Gerjan Navis, Tiny Jaarsma, Stephan J. L. Bakker and Rudolf A. de Boer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Hans L. Hillege

381 papers receiving 27.1k citations

Hit Papers

Urinary Albumin Excretion Predicts Cardiovascular and Non... 2000 2026 2008 2017 2002 2000 2004 2006 2009 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population
    2002 1.2k citations Hans L. Hillege, Dirk J. van Veldhuisen et al. profile →
  2. Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart Failure
    2000 805 citations Hans L. Hillege, Dirk J. van Veldhuisen et al. profile →
  3. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement
    2004 759 citations Hans L. Hillege et al. profile →
  4. Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
    2006 733 citations Hans L. Hillege, Dirk J. van Veldhuisen et al. profile →
  5. Increased Central Venous Pressure Is Associated With Impaired Renal Function and Mortality in a Broad Spectrum of Patients With Cardiovascular Disease
    2009 688 citations Kevin Damman, Vincent M. van Deursen et al. Journal of the American College of Cardiology profile →
  6. Lenient versus Strict Rate Control in Patients with Atrial Fibrillation
    2010 613 citations Isabelle C. Van Gelder, Harry J.G.M. Crijns et al. profile →
  7. Proceedings of the 18th European conference on information systems (ECIS2010)
    2010 577 citations Tommi Tervonen, Hans L. Hillege et al. profile →
  8. Automating network meta‐analysis
    2012 577 citations Gert van Valkenhoef, Bert de Brock et al. profile →
  9. Anemia and Mortality in Heart Failure Patients
    2008 533 citations Kevin Damman, Hans L. Hillege et al. Journal of the American College of Cardiology profile →
  10. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND
    2013 423 citations Rudolf A. de Boer, Pim van der Harst et al. European Heart Journal profile →
  11. What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews
    2017 226 citations Hans L. Hillege et al. profile →
  12. A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction
    2021 209 citations Jasper Tromp, Wouter Ouwerkerk et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans L. Hillege Netherlands 88 16.3k 6.0k 5.1k 4.0k 2.9k 386 27.9k
Giovanni Tripepi Italy 67 5.4k 0.3× 6.6k 1.1× 2.2k 0.4× 2.9k 0.7× 2.1k 0.7× 383 16.8k
Bruce M. Psaty United States 110 20.6k 1.3× 2.8k 0.5× 4.4k 0.9× 6.6k 1.7× 6.4k 2.2× 642 46.3k
Javed Butler United States 91 29.1k 1.8× 1.9k 0.3× 6.2k 1.2× 6.4k 1.6× 3.1k 1.1× 825 42.1k
Aldo P. Maggioni Italy 107 35.8k 2.2× 2.8k 0.5× 5.4k 1.1× 8.0k 2.0× 3.7k 1.3× 873 49.2k
Thomas J. Wang United States 97 21.0k 1.3× 2.2k 0.4× 3.2k 0.6× 4.8k 1.2× 5.0k 1.7× 451 43.2k
Richard Hobbs United Kingdom 74 10.3k 0.6× 1.8k 0.3× 1.9k 0.4× 3.9k 1.0× 3.1k 1.1× 557 24.0k
Curt D. Furberg United States 96 17.5k 1.1× 1.5k 0.3× 4.4k 0.9× 8.8k 2.2× 3.6k 1.2× 340 39.0k
Karol E. Watson United States 55 8.0k 0.5× 1.3k 0.2× 2.5k 0.5× 8.1k 2.0× 1.8k 0.6× 216 22.7k
Stéphane Laurent France 56 15.9k 1.0× 973 0.2× 3.8k 0.8× 2.9k 0.7× 1.2k 0.4× 209 20.8k
Jerry Avorn United States 102 5.7k 0.4× 1.4k 0.2× 1.8k 0.4× 4.0k 1.0× 3.5k 1.2× 517 38.6k

Countries citing papers authored by Hans L. Hillege

Since Specialization
Citations

This map shows the geographic impact of Hans L. Hillege's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans L. Hillege with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans L. Hillege more than expected).

Fields of papers citing papers by Hans L. Hillege

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans L. Hillege. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans L. Hillege. The network helps show where Hans L. Hillege may publish in the future.

Co-authorship network of co-authors of Hans L. Hillege

This figure shows the co-authorship network connecting the top 25 collaborators of Hans L. Hillege. A scholar is included among the top collaborators of Hans L. Hillege based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans L. Hillege. Hans L. Hillege is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vark, Laura C. van, Douwe Postmus, Elisabeth M. W. J. Utens, et al.. (2021). Determinants of quality of life in acute heart failure patients with and without comorbidities: a prospective, observational study. European Journal of Cardiovascular Nursing. 21(3). 205–212. 17 indexed citations
2.
Smit, Marcelle D., Bob Weijs, Anne H. Hobbelt, et al.. (2021). Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study. EP Europace. 23(9). 1359–1368. 11 indexed citations
3.
Streng, Koen W., Jan F. Nauta, Hans L. Hillege, et al.. (2018). Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. International Journal of Cardiology. 271. 132–139. 147 indexed citations
4.
Tromp, Jasper, B. Daan Westenbrink, Wouter Ouwerkerk, et al.. (2018). Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction. Journal of the American College of Cardiology. 72(10). 1081–1090. 208 indexed citations
5.
Lie, Irene, Roma Puronaitė, Hans L. Hillege, et al.. (2018). The dynamics of self-care in the course of heart failure management: data from the IN TOUCH study. Patient Preference and Adherence. Volume 12. 1113–1122. 23 indexed citations
6.
Ferreira, João Pedro, Patrick Rossignol, Biniyam G. Demissei, et al.. (2017). Coronary angiography in worsening heart failure: determinants, findings and prognostic implications. Heart. 104(7). 606–613. 14 indexed citations
7.
Zijlstra, Willemijn M. H., Mark‐Jan Ploegstra, Marcus T.R. Roofthooft, et al.. (2017). Physical Activity in Pediatric Pulmonary Arterial Hypertension Measured by Accelerometry. A Candidate Clinical Endpoint. American Journal of Respiratory and Critical Care Medicine. 196(2). 220–227. 31 indexed citations
8.
Maaten, Jozine M. ter, Kevin Damman, Jennifer S. Hanberg, et al.. (2016). Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure. Circulation Heart Failure. 9(8). 111 indexed citations
9.
Meijers, Wouter C., Rudolf A. de Boer, Dirk J. van Veldhuisen, et al.. (2015). Biomarkers and Low Risk in Heart Failure. Data from COACH and TRIUMPH. European Journal of Heart Failure. 17(12). 1271–1282. 50 indexed citations
10.
Luttik, Marie Louise, Tiny Jaarsma, Peter Paul van Geel, et al.. (2014). Long-Term Follow-Up in Optimally Treated and Stable Heart Failure Patients: Primary Care vs. Heart Failure Clinic. Results of the COACH-2 Study. European Journal of Heart Failure. 16(11). 1241–1248. 52 indexed citations
11.
Deursen, Vincent M. van, Kevin Damman, Adriaan A. Voors, et al.. (2013). Prognostic Value of Plasma Neutrophil Gelatinase–Associated Lipocalin for Mortality in Patients With Heart Failure. Circulation Heart Failure. 7(1). 35–42. 92 indexed citations
12.
Valkenhoef, Gert van, Tommi Tervonen, Bert de Brock, & Hans L. Hillege. (2012). Clinical trials information in drug development and regulation: existing systems and standards. 19 indexed citations
13.
Zhao, Jing, et al.. (2012). ADDIS: an automated way to do network meta-analysis. University of Groningen research database (University of Groningen / Centre for Information Technology). 10 indexed citations
14.
Alssema, Marjan, Rachel S. Newson, Stephan J. L. Bakker, et al.. (2012). One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and Chronic Kidney Disease. Diabetes Care. 35(4). 741–748. 40 indexed citations
15.
Linssen, Gerard C.M., Michiel Rienstra, Tiny Jaarsma, et al.. (2011). Clinical and Prognostic Effects of Atrial Fibrillation in Heart Failure Patients with Reduced and Preserved Left Ventricular Ejection Fraction. European Journal of Heart Failure. 13(10). 1111–1120. 110 indexed citations
16.
Smit, Marcelle D., Alexander H. Maass, Hans L. Hillege, et al.. (2011). Prognostic Importance of Natriuretic Peptides and Atrial Fibrillation in Patients Receiving Cardiac Resynchronization Therapy. European Journal of Heart Failure. 13(5). 543–550. 23 indexed citations
17.
Damman, Kevin, Serge Masson, Hans L. Hillege, et al.. (2011). Clinical outcome of renal tubular damage in chronic heart failure†. European Heart Journal. 32(21). 2705–2712. 171 indexed citations
18.
Vlaar, Pieter J., Karim D. Mahmoud, David R. Holmes, et al.. (2011). Culprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology. 58(7). 692–703. 201 indexed citations
19.
Damman, Kevin, Dirk J. van Veldhuisen, Gerjan Navis, et al.. (2009). Tubular Damage Is Common and Associated With Reduced Survival in Patients With Chronic Heart Failure. Data Archiving and Networked Services (DANS). 1 indexed citations
20.
Damman, Kevin, et al.. (2009). Cardiac Resynchronization Therapy Improves Renal Function. Journal of Cardiac Failure. 15(1). 78–79. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Tripepi Breakdown of academic impact, for papers by Bruce M. Psaty Breakdown of academic impact, for papers by Javed Butler Breakdown of academic impact, for papers by Aldo P. Maggioni Breakdown of academic impact, for papers by Thomas J. Wang Breakdown of academic impact, for papers by Richard Hobbs Breakdown of academic impact, for papers by Curt D. Furberg Breakdown of academic impact, for papers by Karol E. Watson Breakdown of academic impact, for papers by Stéphane Laurent Breakdown of academic impact, for papers by Jerry Avorn
Rankless by CCL
2026